Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma

Tanjina Kader, Jia-Ren Lin, Clemens Hug, Shannon Coy, Yu-An Chen, Ino de Bruijn, Natalie Shih, Euihye Jung, Roxanne J. Pelletier, Mariana Lopez Leon, Gabriel Mingo, Dalia Khaled Omran, Jong Suk Lee, Clarence Yapp, Baby Anusha Satravada, Ritika Kundra, Yilin Xu, Sabrina Chan, Juliann B. Tefft, Jeremy Muhlich, Sarah Kim, Stefan M. Gysler, Judith Agudo, James R. Heath, Nikolaus Schultz, Charles Drescher, Peter K Sorger, Ronny Drapkin, Sandro Santagata

Cancer Discovery. 2024 December 20.

Publication cBioPortal

Contents

Abstract

High-Grade Serous Ovarian Cancer (HGSOC) originates from fallopian tube (FT) precursors. However, the molecular changes that occur as precancerous lesions progress to HGSOC are not well understood. To address this, we integrated high-plex imaging and spatial transcriptomics to analyze human tissue samples at different stages of HGSOC development, including p53 signatures, serous tubal intraepithelial carcinomas (STIC), and invasive HGSOC. Our findings reveal immune modulating mechanisms within precursor epithelium, characterized by chromosomal instability, persistent interferon (IFN) signaling, and dysregulated innate and adaptive immunity. FT precursors display elevated expression of MHC-class I, including HLA-E, and IFN-stimulated genes, typically linked to later-stage tumorigenesis. These molecular alterations coincide with progressive shifts in the tumor microenvironment, transitioning from immune surveillance in early STICs to immune suppression in advanced STICs and cancer. These insights identify potential biomarkers and therapeutic targets for HGSOC interception and clarify the molecular transitions from precancer to cancer.

Immune Suppression in the Fallopian Tube: Insights from Pre-Cancer Atlas
Click to enlarge
Tanjina Kader, PhD presents findings from her 2025 Cancer Discovery Paper to the Ovarian Cancer Syndicate. For a demonstration of exploring the data in cBioPortal see the next video.
Exploring Ovarian Cancer Study in cBioPortal
Click to enlarge
Tanjina Kader, PhD demonstrates using cBioPortal to explore CyCIF image and GeoMx data from her 2025 Cancer Discovery paper.
Complex Interplay between Genetic Mutations, DNA Damage Responses, and Immune System Interactions in Fallopian Tube Precursors
Click to enlarge
Serous Tubal Intraepithelial Carcinoma (STIC) with BRCA2 Mutation (LSP18251).
Micronuclei Rupture in High-Grade Serous Ovarian Carcinoma (HGSOC)
Click to enlarge

Data Access

Data for this paper is available to explore in cBioPortal, including access to associated GeoMx microregional transcriptomic data, ROI annotations, clinical data, and Minerva stories.

Data Access and Data Visualizations

Click any of the following thumbnail images to access associated data or data visualizations. Data visualizations guide readers through the complexities of a large dataset through filters, search, or narrated image waypoints.

LSP16699
Ovarian Cancer with Annotation - LSP15343
Ovarian Cancer with Annotation - LSP15327
Ovarian STIC Spatial Transcriptomic Data from GeoMX and Multiplex Imaging

Curated Minerva Stories

Curated stories provide access to images that have undergone a quality control step to remove failed markers, ensure appropriate channel intensity settings, and provide metadata about the underlying sample and image. Click the Minerva story icon for an interactive view of the full-resolution images.

LSP16814
LSP16699
LSP16698
LSP16697
LSP16696
LSP11060
LSP11064
LSP11068
LSP11072
LSP11076
LSP11088
LSP15327
LSP15335
LSP15339
LSP15343
LSP15347
LSP15355
LSP15359
LSP16136
LSP16138
LSP16141
LSP16144
LSP16147
LSP16150
LSP16153
LSP16156
LSP16159
LSP17722
LSP17730
LSP17734
LSP17758
LSP17762
LSP17766
LSP17786
LSP17790
LSP17818
LSP17822
LSP17850
LSP18301
LSP18305
LSP18309
LSP18313
LSP18317
LSP19412
LSP19416
LSP19420